Canadian Physicians Proclaim Remifemin (TM) "Most Promising Herbal Product" in Complementary Approach to Menopause
In its commitment to deliver the highest standards of health care to Canadian women, the Society of Obstetricians and Gynaecologists of Canada (SOGC) compiled a comprehensive report on menopause and osteoporosis in its November and December 1998 issues of the "Journal SOGC." In its review of complementary approaches, the organization concluded that Remifemin (TM) is a "useful alternative" for menopause. The medical publication cites numerous studies on the black cohosh product and regards Remifemin (TM) as "the most promising herbal product.".
The article, along with the medical society's complete collection of articles was approved for distribution to the Canadian Consensus Conference on Menopause and Osteoporosis. The Canadian Consensus defines the standard of care for menopausal women in Canada..
Additionally, they assist women and their caregivers in making informed choices to improve the quality of life by promoting health and preventing disease..
Remifemin (TM) is manufactured by the German pharmaceutical company, Schaper and Brummer. The product is standardized for its key compounds and marketed exclusively in North America by PhyoPharmica, and FDA-registered manufacturer of nutritional supplements..
Among the leading US health care professionals recommending the natural product are noted author and Yale-trained psychiatrist, Harold H. Bloomfield, MD, and Varro Tyler, PhD, ScD, Dean Emeritus of the Purdue University School of Pharmacy and Pharmacal Sciences. PhytoPharmica manufactures over 200 natural medicines, nutritional supplements, vitamins and herbal extracts, and is headquartered in Green Bay, Wisconsin. The company was the first to introduce Ginkgo biloba and the standardization of botanicals to the United States health market. All PhytoPharmica formulations are lab-tested for purity, potency and bioavailability, and the company distributes its extensively researched product line to health care professionals nationwide.
For More Information, Contact:
(Reprint, Townsend Letter for Doctors & Patients, June, 1999 edition)
The Light Party,
Your Feedback is important to us. Please send us E-Mail.
Our E-mail address is on our Home Page
| Top or Page